Recurrent Osteosarcoma Active Not Recruiting Phase 2 Trials for Cabozantinib (DB08875)

Also known as: Osteosarcoma recurrent / Osteogenic sarcoma recurrent

IndicationStatusPhase
DBCOND0028757 (Recurrent Osteosarcoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02243605Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing SarcomaTreatment